Advertisement

Topics

Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

05:39 EDT 12 Aug 2018 | BioPortfolio Reports

Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report


Summary


Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Express Scripts Holding Company ESRX or 'the company', the largest standalone pharmacy benefit management PBM company in the US, was created in 2012 through the merger of Express Scripts ESI and Medco Health Solutions Medco. The company classifies its business into two reportable segments: Pharmacy Benefit Management PBM and Other Business Operations. It offers a range of services including: clinical solutions, specialized pharmacy care, home delivery pharmacy services, specialty pharmacy services, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, Medicare, Medicaid and Public Exchange offerings, administration of a group purchasing organization and consumer health and drug information. It also provides distribution services of specialty pharmaceuticals and medical supplies; and consulting services. ESRX also operates in Canada. It is headquartered in St. Louis, Missouri.


Scope


Detailed information on Express Scripts Holding Company required for business and competitor intelligence needs

A study of the major internal and external factors affecting Express Scripts Holding Company in the form of a SWOT analysis

An indepth view of the business model of Express Scripts Holding Company including a breakdown and examination of key business segments

Intelligence on Express Scripts Holding Company's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Express Scripts Holding Company, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Express Scripts Holding Company and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Express Scripts Holding Company as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Express Scripts Holding Company's business structure, strategy and prospects.

Original Article: Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Express Scripts Holding Company Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...